Skip to search formSkip to main contentSkip to account menu

DW-116

Known as: DW 116 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
DW‐116 is a newly developed fluoroquinolone antibacterial with a broad spectrum against both Gram‐positive and Gram‐negative… 
2003
2003
We have recently reported that the fluoroquinolone antibacterial DW-116 induces a significant developmental toxicity in rat. The… 
2003
2003
2000
2000
Abstract DW-116, 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-l-piperazinyl)-1, 4-dihydro-4-oxoquinolone-3-carboxylic acid… 
1998
1998
The safety, tolerability and pharmacokinetics of DW-116, a new fluoroquinolone with a broad antibacterial spectrum, were… 
1998
1998
DW-116 is a new fluoroquinolone antimicrobial agent with a broad spectrum. In order to elucidate the resistance mechanism to DW… 
1997
1997
DW-116 is a novel fluoroquinolone that was two- to four-fold more active than rufloxacin and less active than sparfloxacin… 
1997
1997
The metabolic disposition of the new fluoroquinolone antibacterial agent DW116 has been studied in Sprague-Dawley rats. The… 
1997
1997
The objectives of this study were to characterize the pharmacokinetics of 1-5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1…